Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 2/20 | 0.34 |
| ▸ | MPO | P05164 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6837854 | 0.74 | KDM4E (0.34) | KDM4ELMNAMAPTALDH1A1POLB | |
| SCHEMBL80903 | 0.69 | KDM4E (0.33) | KDM4ELMNAMAPTALDH1A1POLB | |
| SCHEMBL51669 | 0.67 | KDM4E (0.41) | KDM4ELMNAMAPTALDH1A1POLB | |
| SCHEMBL1521620 | 0.65 | ALDH1A1 (0.33) | KDM4ELMNAMAPTALDH1A1POLB | |
| SCHEMBL16329822 | 0.65 | DYRK1A (0.49) | PTGS2DYRK1ACCNKCDK12PTGS1 | |
| SCHEMBL12612219 | 0.64 | KDM4E (0.33) | KDM4ELMNAMAPTALDH1A1GPR3 | |
| SCHEMBL17417258 | 0.64 | KDM4E (0.33) | KDM4ELMNAMAPTALDH1A1POLB | |
| SCHEMBL19700610 | 0.63 | DYRK1A (0.40) | PTGS2DYRK1ACCNKCDK12PTGS1 | |
| SCHEMBL12145717 | 0.63 | KDM4E (0.41) | KDM4ELMNAMAPTALDH1A1POLB | |
| SCHEMBL18130849 | 0.63 | MPO (0.40) | KDM4ELMNAMAPTALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 868 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260068424-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-03-05 | — | — | US | claimed |
| CN-113421989-B | Light-emitting element and composition useful for manufacturing the same | 住友化学株式会社 | 2025-05-02 | — | — | CN | claimed |
| CN-113698387-B | Heterocyclic compound and organic light-emitting device including the same | 三星显示有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-111987230-B | Organic light emitting device and apparatus including the same | 三星显示有限公司 | 2025-02-28 | — | — | CN | claimed |
| US-12060344-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-08-13 | — | — | US | claimed |
| US-11925106-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-03-05 | — | — | US | claimed |
| CN-117024330-A | Heterocyclic compound, composition comprising same, and organic light-emitting device comprising same | 三星电子株式会社 | 2023-11-10 | — | — | CN | claimed |
| US-20230320113-A1 | Light Emitting Device and Composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-05 | — | — | US | claimed |
| EP-3522248-B1 | LIGHT-EMITTING ELEMENT, AND COMPOSITION USEFUL FOR MANUFACTURING LIGHT-EMITTING ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2023-08-09 | — | — | EP | claimed |
| EP-4220746-A1 | LIGHT EMITTING ELEMENT AND COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-02 | — | — | EP | claimed |
| US-20090246575-A1 | HYDROGEN STORAGE MATERIAL AND RELATED SYSTEM | GENERAL ELECTRIC COMPANY (US) | 2009-10-01 | — | — | US | claimed |
| US-20090236974-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-09-24 | — | — | US | claimed |
| US-7504657-B2 | Organic electroluminescent element, display and illuminator | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-03-17 | — | — | US | claimed |
| US-20080248345-A1 | METHOD AND APPARATUS FOR ELECTROCHEMICAL ENERGY CONVERSION | GENERAL ELECTRIC COMPANY (US) | 2008-10-09 | — | — | US | claimed |
| US-20080248339-A1 | METHOD AND APPARATUS FOR ELECTROCHEMICAL ENERGY CONVERSION | GENERAL ELECTRIC COMPANY (US) | 2008-10-09 | — | — | US | claimed |
| EP-1923386-A2 | Carbamate caspase inhibitors and uses thereof | Vertex Pharmceuticals Incorporated (US) | 2008-05-21 | — | — | EP | claimed |
| US-20070200124-A1 | Organic Electroluminescent Element, Display And Illuminator | KONICA MINOLTA HOLDINGS, INC. (JP) | 2007-08-30 | — | — | US | claimed |
| EP-1784056-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2007-05-09 | — | — | EP | claimed |
| EP-1268425-A2 | CARBAMATE CASPASE INHIBITORS AND USES THEREOF | Vertex Pharmaceuticals Incorporated (US) | 2003-01-02 | — | — | EP | claimed |
| WO-2001072707-A2 | CARBAMATE CASPASE INHIBITORS AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2001-10-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11925106-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including the condensed cyclic compound | CCNB1, CCNA1, CCNT1 | PTGS2 1730/4885KDM4E 4280/4885LMNA 1487/4885 |
| US-20260068424-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, SIGMAR1, GLRA1 | PTGS2 3825/4885KDM4E 3780/4885LMNA 715/4885 |
| US-12060344-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CCNT1, CCNA1, CYP1B1 | PTGS2 1737/4885KDM4E 3931/4885LMNA 1528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.